Think you’re immune from Inflation Reduction Act (IRA) implications because your drug wasn’t selected?
The Inflation Reduction Act affects all pharma manufacturers, not only the companies with a drug in question. That’s because reducing the price of an expensive drug will have a ripple effect on all competitive drugs. Preventing revenue leakage while remaining confidently compliant is just as critical for you as it is for the manufacturers currently entrenched in the IRA negotiation process. You can master the complexities involved with pricing, contracts, discounts and audit trails. This eBook will show how to get on the right path to compliance.
Lower your risks: prevent the risk of compliance penalties
Protect your revenue: reduce revenue leakage
Improve your visibility: operate in predictive mode
